Technology61/100

Is IBM-International Business Machines a buy?

Tuesday 14 July 2026

Why now: IBM is being repriced in real time after management released selected preliminary 2Q 2026 results that came in below expectations, creating a rare “reset” moment for a mega-cap, dividend-paying enterprise name. The timing edge is not momentum; it is the chance to re-underwrite the long-term cash-flow story at a materially lower print before the full 2Q release and call on July 22, 2026.

Upside: If IBM can show on the July 22, 2026 earnings call that the Q2 miss was mainly timing and capex mix (not a lasting demand problem), a partial valuation re-rating back toward the pre-gap area could create meaningful upside from the current premarket print. A reasonable 12-month upside case is a recovery toward the mid-$260s to high-$280s if execution stabilizes and guidance holds, but this depends on confidence rebuilding, not just one quarter of numbers.

Risks: The near-term risk is that the preliminary disclosure is the first step in a broader guide-down cycle, especially if mainframe-related performance and attached software remain weaker than expected. The second key risk is that enterprise budgets continue shifting toward non-IBM AI infrastructure purchases, keeping IBM’s growth more muted than the market previously priced in.